
NYSE:CVS
This summary was created by AI, based on 9 opinions in the last 12 months.
CVS Health Corp has shown positive momentum, recently beating earnings and revenue expectations, which has contributed to an 8% surge in share price, marking a three-year high. Although the stock appears cheap based on surface valuation metrics, experts caution that its low price may reflect underlying issues, such as questions around the retail pharmacy space and the impact of government regulations on their managed care business. The company is in the midst of a turnaround, bolstered by strong leadership and an impressive improvement in its health insurance sector. Analysts express mixed feelings, noting potential for upside but recommending caution until further visibility is achieved regarding its recovery. A significant percentage of analysts see potential gains towards the price target of $95.00, but there remain concerns about execution risks and the overall state of the business model.
Walgreens (WBA-Q) is proposing to buy Rite Aid (RAD-N). WBA-Q and CVS-N are obviously the leading US drug retailers. She likes the drug retailing and the Pharmacy Benefit management businesses of CVS-N. They have done a couple of transactions in 2015 that she thinks will be accretive in 2016. They bought Target’s 2000 pharmacies. They say only 5-10% of Target customers use the pharmacy and aim to increase that. They announced a 21% increase in the dividend and 10-14% earnings growth for the next few years. The number of scripts per person increases as people age. 2% dividend that is increased on a regular basis. Buy on a pullback.
Sold his holdings about a month ago in order to take some profits. Technically it has started to roll over a little and fell below the 200 day moving average. He was starting to see lower highs and lower lows. Likes the name quite a bit. It is trading at nice fundamentals and valuations, 18X forward earnings and a growth rate near 15%. This is a name he would be happy to re-enter.
Likes the space, but sold his holdings a few months ago when it broke a long upward trend. Chart shows a little support at around $80. There have been a lot of costs that have been uncertain for them. Thinks long term this will be a good name and he would like to get back into it. You have to wait until it breaks out at around $115. He would watch for something between the 125-150 daily moving averages.
One of the leading drug retailers in the US with about 8000 locations. That is about two thirds of their earnings and the other is their pharmacy benefit business (PBM). Both work well for them. They can leverage off their retail base accessing drugs for their customers. Recently acquired Target’s 1600 pharmacies and will rebrand them as CVS pharmacies. Also, bought Omnicare which gives them new long care operators. Dividend yield of 1.49%.
CVS Health (CVS-N) or Walgreen Boots Alliance (WBA-Q)? He owns both and has done very well with them. They have both been quite dynamic in their operations over the last while. This one made some very bold moves, some of them internal. They stopped selling cigarettes, which was a good strategic move. On a valuation basis this one is a little more attractive, but it is really a toss-up.
CVS (CVS-N) or Walgreen (WBA-Q)? He owns both and they are both great opportunities. Demographically they are both in a sweet spot with the aging of the population and the need for prescription drugs. Couple that with Obama care, which mandates that people have insurance that will allow them to get those drugs. They just did a deal for Omnicare that provides long-term care for the elderly, and writes a ton of prescriptions. This trades at a couple of multiple points cheaper than Walgreen, and also its earnings predictability is a little bit higher, but he would own both.
CVS Health (CVS-N) or Walgreen Boots Alliance (WBA-Q)? These are so similar. They are both benefiting from similar trends. This has your pharmacy benefits manager. They are both benefiting from increasing drug usage and the whole story of the population getting older. You are getting some very good assets here and some very good secular growth over a number of years. Doesn’t think you will get hurt on either one.
Changing themselves so they are not just a pharmacy. They have become the largest provider of walk in clinics, replacing emergency rooms in the US. They are increasingly providing a big menu of ambulatory health services. They fill 25% of the prescriptions in the US and the biggest growth in spending in health care is in prescription medication. It is an interesting company. They just recently added it to their portfolio. CVS is really onto something, onto a trend and doing something that the other pharmacies haven't figured out yet. He is quite impressed by it.
They are also in the pharmacy benefits management. They have clinics and are into long term care. They will grow in the low to mid-teens. They are focused on outcomes, which is significant in the US.